Category Archives: Biologics

Formats of bispecific antibodies (BsAbs)

Formats of bispecific antibodies (BsAbs) Many formats have been developed for BsAb generation as listed in the following table. Pipeline and MOA (mechanism of action) of bispecific antibodies (BsAbs) Bridge of 2 cells (engagers) By binding with 2 antigens from 2 different cells, the BsAbs can physically link them together, thus these kinds of BsAbs […]

Introduction about bispecific antibodies?(BsAbs)

Introduction about bispecific antibodies (BsAbs) Bispecific antibodies (BsAbs) are designed to bind two different epitopes or antigens, which leads to multiple mechanistic functions with synergistic effects. The attractive feature is their potential for novel functionalities, which do not exist in mixtures of the parental or reference antibodies. Till now, more than 200 BsAb-based clinical trails […]

Human Immunodeficiency Virus (HIV) neutralizing antibodies (NAb)

Human Immunodeficiency Virus (HIV) neutralizing antibodies (NAb) The glycoprotein (gp) 120 subunit is an important part of the envelope spikes that decorate the surface of HIV-1 and a major target for neutralizing antibodies. FDA approved neutralizing antibodies (NAb) and our products 1. SARS-CoV-2 neutralizing antibodies (NAb) SARS-CoV-2, the novel coronavirus responsible for the ongoing COVID-19 […]

SARS-CoV-2 neutralizing antibodies (NAb)

SARS-CoV-2 neutralizing antibodies (NAb) SARS-CoV-2, the novel coronavirus responsible for the ongoing COVID-19 pandemic, has been spreading rampantly. The global scientific community has responded rapidly to understand immune correlates of protection to develop vaccines and immunotherapeutic against the virus. The RBD of spike plays a critical role in the very first step of the virus […]

FDA approved neutralizing antibodies (NAb) and our products

FDA approved neutralizing antibodies (NAb) and our products 1. SARS-CoV-2 neutralizing antibodies (NAb) SARS-CoV-2, the novel coronavirus responsible for the ongoing COVID-19 pandemic, has been spreading rampantly. The global scientific community has responded rapidly to understand immune correlates of protection to develop vaccines and immunotherapeutic against the virus. The RBD of spike plays a critical […]

How neutralizing antibody (NAb) work (mechanisms of action, MOA)

Definition–What is neutralizing antibody (NAb)? Regarding neutralizing antibody activity, Neutralization can be achieved through four main mechanisms2: (1)NAbs binding to viral surface proteins and blocking their interaction with the host cell receptor and infection; (2)NAbs binding to viral protein epitopes that interact with host cell coreceptors that are key for viral infection; (3)NAbs binding to viral […]

How to produce neutralizing antibody (NAb) (production)

How to produce neutralizing antibody (NAb) (production) Antibodies are made by B-cells in the bone marrow. Bone marrow has been long thought to be a hematopoietic organ. When B-cells are created, they begin to produce antibodies that will bind to specific antigens. Antigen-specific antibody producing, long-term lived plasma cells are largely found in the bone […]

Introduction of neutralizing antibody (NAb)

Definition–What is neutralizing antibody (NAb)? A neutralizing antibody (NAb) is an antibody that is responsible for defending cells from pathogens, which are organisms that cause disease. They are produced naturally by the body as part of its immune response, and their production is triggered by both infections and vaccinations against infections1. A neutralising antibody rapid […]

Virus like particles (VLP) for drug discovery

Drug discovery against infectious disease requires the standard biological assays. The biological assay for viral disease is depends on the infection of cultured cells with virus and observation of its effect by microscopic techniques, viral load quantification using plaque assay, or reverse transcription-PCR.  This conventional method is time consuming and limits the screening of large […]

Measles virus (MeV) neutralizing antibodies (NAb)

Measles virus (MeV) neutralizing antibodies (NAb) Measles virus (MeV) causes an extremely transmissible respiratory disease and it has also been used as an oncolytic platform. MeV enter into the cells through the cellular receptors such as SLAM (signaling lymphocyte-activating molecule) and PVRL4 (poliovirus receptor-like 4) (nectin-4). Hence, the antibodies against PVRL4 could block measles virus infections. […]